Article by Bao Tran (Founder, PatentPC) and Adhip Ray (Consultant, PatentPC).
What current public patent data shows about AI acceleration, patent ownership, founder exposure, and the shrinking room for casual IP strategy
| Key findings Global patenting is still climbing. WIPO reported 3.7 million patent applications worldwide in 2024, up 4.9% from 2023 and the fastest year-on-year growth since 2018. The GenAI patent surge has moved far beyond the 2023 baseline. WIPO’s 2026 GenAI update reports that published GenAI patent families rose from roughly 14,000 in 2023 to more than 37,800 in 2025, with more than 56,000 published in 2024 and 2025 combined. The technical center of gravity has shifted. LLM patent families have overtaken GANs in WIPO’s updated analysis, with more than 14,100 LLM patent families published in 2025 versus about 5,245 GAN patent families. Patent ownership is no longer only a familiar Big Tech story. WIPO’s 2026 analysis identifies SoftBank as the largest cumulative GenAI patent owner, ahead of Tencent, Ping An, Baidu, Alphabet, Microsoft, IBM and others. PatentPC’s strategic interpretation is that founders should treat patent planning as an early exposure-management issue, not as a cleanup task after launch, pilots, fundraising or technical disclosure. |
| Scope note: what this brief is and is not This is a PatentPC data-backed analysis built from public WIPO and USPTO sources. It uses source-backed public figures where the numbers are shown. It also includes a clearly labeled PatentPC qualitative framework for founder exposure. This brief does not claim to run a new company-level SEC Form D matching study. It does not calculate dollar transaction value from patent assignments. It does not present a reproducible sector-level CPC patent-crowding index. Those would require separate empirical datasets and matching procedures. Where this brief draws a strategic conclusion, the language identifies it as PatentPC’s interpretation of public patent activity rather than as a direct empirical finding. |
Founders do not usually lose patent leverage in one dramatic moment. They lose it quietly. A technical breakthrough gets shown in an investor deck. A pilot customer sees how the workflow really works. A demo reveals the architecture. A launch page explains the product in just enough detail for the market to understand where the value sits. A competitor starts filing around the same technical problem while the startup is still refining product-market fit.
That is the real reason strategic patents matter now more than ever. Not because every startup should collect patents. Not because a patent automatically creates a moat. And not because filing a vague “AI patent” makes a company defensible. Strategic patents matter because the time between technical invention and market exposure has become dangerously short in many founder-heavy markets.
PatentPC’s interpretation of the current public data is simple: rapid growth in published patent activity increases the strategic cost of waiting, especially in fields where multiple teams are pursuing similar architectures, workflows, control systems, diagnostics, data pipelines or infrastructure layers. The data does not prove that a patent causes funding, valuation or exit value. It does show that the public patent record is moving quickly around the same technical areas founders are racing to commercialize.
1. The present moment is more urgent than the old 2023 data suggested
Any present-day founder patent strategy has to start with current data. A “now more than ever” argument should not rely only on datasets ending in 2023 when newer public patent indicators materially change the story.
WIPO’s World Intellectual Property Indicators 2025 highlights report says innovators filed 3.7 million patent applications worldwide in 2024, up 4.9% from 2023. That was the fastest year-on-year growth since 2018. WIPO also reports that worldwide patent filings have nearly doubled from just under 2 million in 2010 to 3.7 million in 2024.

For founders, the most important point is not the global count by itself. The point is that technical disclosure is being documented at scale. Each new application adds another public technical record. In some fields, that record may become prior art, a competitive signal, a claim-design constraint, or a map of where incumbents and fast-moving challengers are aiming their R&D.
PatentPC’s strategic interpretation: a fast-rising patent environment does not mean a founder should file more patents blindly. It means a founder should decide earlier which inventions are strategically worth protecting and which should be kept as trade secrets, published defensively, or left alone.
2. GenAI patent activity has entered a new phase
The GenAI numbers are the clearest reason the article needed an update. WIPO’s 2026 Technology SPARK update extends the GenAI analysis through 2025. It reports that published GenAI patent families rose from approximately 14,000 in 2023 to more than 37,800 in 2025. More than 56,000 new GenAI patent families were published in 2024 and 2025 combined, exceeding the entire cumulative output from 2014 through 2023.

This changes the founder story. The old point was that GenAI patenting was accelerating. The current point is stronger: the post-ChatGPT patent wave has now started to show up in the public record after the usual filing-to-publication lag. A founder building in AI in 2026 is not only competing against products. The founder is also entering a public technical record that has expanded sharply in the previous two years.
That still does not mean “file an AI patent” is good advice. The better advice is more precise: identify the technical layer competitors would need to copy if the product works. For an AI company, that layer may be the model workflow, data preparation system, retrieval architecture, inference method, safety-control mechanism, hardware-software integration, enterprise deployment path, or vertical application logic.
3. The GenAI race has shifted from GANs to LLMs, diffusion and multimodal systems
The updated WIPO data also changes the technical story. In the 2024 landscape, GANs were still a dominant model category. In the 2026 update, WIPO reports that LLM patent families have overtaken GANs. Between 2014 and 2025, WIPO identifies approximately 20,900 LLM patent families and about 18,800 GAN patent families. In 2025 alone, LLMs had more than 14,100 patent-family publications, compared with about 5,245 for GANs.

This matters because patent strategy follows technical architecture. A founder building around LLMs does not have the same patent questions as a founder building around image generation, synthetic data, autonomous control, document reasoning, drug discovery, code generation or customer-support automation. The core patentable contribution may not be the user-facing prompt box. It may be how the system retrieves context, constrains output, routes tasks, evaluates confidence, coordinates agents, integrates proprietary data, reduces latency, or controls a downstream technical process.
PatentPC’s interpretation: the most dangerous founder mistake is to protect the visible feature while leaving the technical system unprotected. The public data shows that filings are now clustering around the underlying model categories and modes that power commercial GenAI products. That makes invention capture more important, not less.
4. The GenAI patent race is geographically broader than a simple US-versus-China story
China remains the largest source of GenAI patent-family publications by volume. WIPO reports that China-based inventors published more than 43,000 GenAI patent families in 2024 and 2025 alone, more than China’s entire output from 2014 through 2023. But the updated data also show rapid relative growth elsewhere. WIPO reports 2023-2025 CAGR figures of 92% for the United States, 210% for Japan, 85% for Germany, 109% for Canada and 124% for Switzerland.

For founders, the practical takeaway is that patent competition is no longer local. A US founder may be competing for customers in one market, engineers in another, cloud infrastructure in another, and patent positioning against companies and institutions across several jurisdictions. This does not mean every founder needs a global portfolio from day one. It does mean that public patent intelligence should be part of the competitive map earlier than many startups assume.
5. Patent ownership is not just a familiar Big Tech ranking anymore
One of the most important updates is the ownership picture. WIPO’s 2026 analysis identifies SoftBank as the largest cumulative GenAI patent owner, with 2,985 published patent families between 2014 and 2025, virtually all filed in 2023 and published in 2025. Tencent, Ping An, Baidu, the Chinese Academy of Sciences, State Grid, Alphabet, Zhejiang University, Microsoft and IBM follow in the top 10.

This is a founder-relevant signal. The GenAI patent race is not only about internet companies. It now includes telecommunications, finance, infrastructure, utilities, chips, research institutions and industrial companies. That matters because many startups sell into exactly those sectors. A founder may think the company is building a workflow product. A large enterprise may see the same system as infrastructure, a control layer, a regulated process, a data asset, or a platform dependency worth patenting around.
The lesson is not paranoia. It is precision. If the startup’s real advantage is a technical process that a much larger company would need to replicate, route around, acquire or license, the founder should not wait until the product is already public before deciding whether that process deserves patent protection.
6. The strategic exposure clock is not the same as a universal legal deadline
Founders often hear that a “patent clock” starts when an invention is exposed. That phrase is catchy, but it can be legally imprecise. Public-disclosure consequences differ by jurisdiction and depend on the facts. Some jurisdictions are less forgiving than others. Some disclosures may matter more than others. Some conversations are confidential; others are not. Founders should obtain advice about filing timing before launches, publications, pilots, investor decks, partner discussions or other nonconfidential disclosures.
That is why “strategic exposure clock” is the better phrase. It describes the business-risk window in which a technical advantage starts becoming visible to people outside the company. The legal consequences may vary, but the strategic consequences are often immediate: more people know what matters, more teams can file nearby, and the startup may have less room to shape the patent story around the core invention.
PatentPC’s interpretation: the public patent surge makes early invention triage more valuable. A founder should not ask “Do we need patents someday?” The better question is “Which technical disclosures are too important to expose before we have made a filing decision?”
7. Current USPTO eligibility guidance makes AI patent strategy more technical, not more generic
AI patent strategy also has to account for patent-eligibility risk. USPTO’s current subject-matter-eligibility page states that the Office’s guidance explains how USPTO personnel, including examiners and PTAB administrative patent judges, should evaluate claims under 35 U.S.C. 101. The page lists the 2024 AI subject-matter eligibility update, the 2025 reminders on evaluating eligibility, and 2026 materials related to subject-matter eligibility declarations.
For founders, the practical point is not to memorize eligibility doctrine. The point is to avoid reducing the invention to “use AI to perform a business task.” Stronger AI patent work usually requires a clear technical story: what the system improves, how it is implemented, why the architecture matters, what technical constraint it solves, and how the claimed method is more than an abstract outcome.
| Founder translation: A weak AI patent story says: “We use AI to automate X.” A stronger AI patent story explains: “Here is the technical system that makes X work better: the data pipeline, model-routing logic, inference constraint, feedback loop, device integration, security mechanism or technical control process.” |
8. PatentPC Founder Strategic Exposure Matrix
Exact 0-100 scores in a qualitative founder exposure framework can create a precision problem. Unless the model is fully reproducible and the component scores are disclosed, exact scores such as 81, 82 or 86 can look more scientific than they are. For that reason, this brief uses a qualitative PatentPC Founder Strategic Exposure Matrix rather than exact numeric scores.
This is a strategic framework, not a measured empirical index. It combines public patent-activity signals with PatentPC’s interpretation of founder exposure. The components are disclosed below so readers can see how the classification is formed.
| Component | Question it asks | Evidence type used | Weight |
| Patent activity acceleration | Is the public patent record moving quickly around this technology? | WIPO/USPTO activity signals; technology-specific public patent trends | 30% |
| Technical copyability / visibility | Can competitors understand or reproduce the important layer once it is exposed? | Founder-facing assessment of product visibility, demo risk and implementation opacity | 20% |
| Claim-complexity / eligibility risk | Will useful claims require careful technical drafting rather than broad functional language? | USPTO eligibility context; software/AI/hardware/diagnostic claim complexity | 20% |
| Transfer / enforcement relevance | Do patents plausibly matter in ownership transfers, licensing, disputes or diligence? | USPTO assignment and litigation datasets as public signals of IP movement/enforcement environment | 15% |
| Operational disclosure risk | Does the company need to show the technical system to customers, partners or investors early? | Strategic assessment of pilots, demos, regulatory review, enterprise sales and technical integrations | 15% |
Table 1. Component-level methodology for the PatentPC Founder Strategic Exposure Matrix. This is a qualitative strategic framework, not a reproducible empirical score.
The sector classification below uses High, Medium and Selective rather than exact scores. “High” means patent planning should generally happen early if the company has real technical depth. “Medium” means patent strategy depends heavily on the technical implementation. “Selective” means patents may matter, but only for specific technical systems rather than ordinary product features.
| Sector | Activity acceleration | Copyability / visibility | Claim complexity | Transfer / enforcement relevance | Disclosure risk | Overall exposure |
| AI infrastructure | High | High | High | High | High | Very high |
| Medical AI / diagnostics | High | Medium | High | High | High | Very high |
| Robotics / autonomy | High | Medium | High | High | High | Very high |
| Cybersecurity AI | High | High | High | Medium | High | High |
| Fintech authentication / fraud | Medium | High | High | Medium | High | High |
| Industrial automation | Medium | Medium | Medium | High | Medium | High |
| Climate hardware / batteries | Medium | Medium | High | High | Medium | High |
| Education AI | Medium | High | Medium | Low | Medium | Medium / selective |
| Consumer AI apps | Medium | High | High | Low | Medium | Selective |
How to read this matrix: if a sector is “Very high,” the founder should not wait until after launch to discuss patents. If a sector is “Selective,” patents may still matter, but the company must identify a concrete technical system. Consumer AI features, for example, usually do not become defensible just because they use a model API. A specific inference architecture, latency-reduction method, privacy-preserving workflow, multimodal interface mechanism or device integration may be different.
9. Public patent data answers different questions. It should not be mashed into one chart.
Patent datasets are often tempting to compare by raw size, but that can mislead. A single chart should not compare patent documents, assignment records, patents and applications involved in assignments, litigation docket documents and litigation cases as if they were the same unit. Those are different units. The better approach is to map each dataset to the founder question it can actually answer.

The USPTO Patent Assignment Dataset is useful because it records assignments and other transactions involving patents and applications. It can show ownership movement, security interests, mergers, name changes and recorded transfers. It does not, by itself, prove financial value. A patent assignment record is a transaction signal, not a valuation model.
The USPTO Patent Litigation Dataset is useful because it describes district-court patent cases and patents-in-suit. It can help researchers understand enforcement environments and litigation exposure. It does not tell a founder whether a particular patent is strong, valid, infringed or commercially valuable without legal analysis.
PatentsView and CPC data are useful for technology mapping. They can support a real sector-level crowding study, but this brief does not claim to have completed that study. A reproducible crowding analysis would need CPC mapping, assignee normalization, family deduplication, recent-period comparison, and manual validation of noisy categories.
10. What founders should actually protect earlier
The right lesson is not “patent everything.” That is expensive, unfocused and often strategically weak. The better lesson is to identify the technical layer that would hurt if a competitor copied it.
- For AI infrastructure companies, that layer may be model routing, inference optimization, memory handling, orchestration, evaluation, privacy controls or deployment architecture.
- For medical AI and diagnostics companies, it may be signal processing, clinical data preparation, measurement workflows, device integration, diagnostic constraints or decision-support architecture.
- For robotics and autonomy companies, it may be perception, sensor fusion, planning and control, actuation logic, calibration, safety systems or hardware-software coordination.
- For cybersecurity companies, it may be anomaly detection, response automation, identity verification, event correlation, attack-surface modeling or secure execution architecture.
- For fintech and fraud systems, it may be transaction classification, authentication logic, risk scoring architecture, secure model deployment or privacy-preserving identity workflows.
- For climate hardware and battery companies, it may be materials, cell structures, thermal control, manufacturing steps, monitoring systems or optimization methods.
- For education and consumer AI companies, patents usually require more than a good product idea. The founder needs a technical implementation that improves how the system works, not merely a content workflow or interface concept.
Put simply: do not patent the shiny screen if the moat lives in the engine room.
11. The founder playbook: how to act before the exposure window closes
- Write down the real technical advantage in plain English. Do not start with claims. Start with what the system does differently and why it matters.
- Separate visible features from hidden technical systems. A feature is what users see. A patentable technical system is often what makes the feature work.
- Review planned disclosures before they happen. Investor decks, pilots, product demos, architecture blogs, GitHub repos, conference talks and partner materials can all reveal different levels of technical information.
- Decide what should be filed, kept secret, published defensively or ignored. Patent strategy is allocation, not hoarding.
- Use provisional filings carefully when timing is tight. They can preserve a filing position, but only if the disclosure is technically rich enough to support later claims.
- Build claim layers around the roadmap. One broad idea is rarely enough. Strong portfolios often protect architecture, workflow, data treatment, device integration, improvements and fallback positions.
- Revisit the strategy after major product changes. AI products evolve fast. A patent strategy from six months ago may not protect the system the company is actually building now.
The founder who waits until the market understands the invention may still be able to file. But the founder may be filing from a weaker position. The strongest patent strategy is not reactive. It is timed to the moment before the technical advantage becomes obvious to everyone else.
12. When founders should talk to a patent strategist
Founders should not wait for a lawsuit, acquisition offer or investor diligence request before asking serious patent questions. The right time is often before the company exposes the invention.
- Before a public launch or major product demo.
- Before sharing technical architecture with investors or strategic partners.
- Before enterprise pilots where customers see the workflow closely.
- Before publishing model, data, device, workflow or performance details.
- Before entering a sector where large companies are visibly filing around similar technology.
- Before the company decides whether a technical advantage should be patented or kept as a trade secret.
| PatentPC takeaway Strategic patents are not paperwork. They are timing tools. They help founders decide what must be protected before the market, competitors, investors, partners and acquirers can see the technical layer that makes the company valuable. The goal is not to file more patents. The goal is to file the right patents early enough, with enough technical depth, to preserve future leverage. |
Methodology and source notes
Data status. This brief uses WIPO 2025 global patent indicators, WIPO 2026 GenAI Technology SPARK data, USPTO AI Patent Dataset descriptions, USPTO subject-matter-eligibility materials, USPTO Patent Assignment Dataset descriptions and USPTO Patent Litigation Dataset descriptions. Figures that contain numbers use public figures reported in those sources or simple derivations stated in the figure note.
Interpretation status. The phrase “strategic exposure clock,” the Founder Strategic Exposure Matrix and the founder playbook are PatentPC’s strategic interpretation. They are not direct legal rules, not valuation findings, and not empirical proof that patents cause financing outcomes.
Legal precision. Public disclosure can affect patent rights differently across jurisdictions and fact patterns. Founders should obtain advice before launches, publications, pilots, investor disclosures or other nonconfidential technical disclosures.
Citations. The source list below is included so readers can verify each public-data claim if they like.
- WIPO World Intellectual Property Indicators 2025 highlights, Patents highlights: https://www.wipo.int/web-publications/world-intellectual-property-indicators-2025-highlights/en/patents-highlights.html
- WIPO press release: “GenAI Innovation Soaring, With Patent Activity Nearly Tripling in Two Years,” July 14, 2026: https://www.wipo.int/pressroom/en/articles/2026/article_0012.html
- WIPO Technology SPARK: Patent Trends Update in GenAI, 2026: https://www.wipo.int/web-publications/spark-patent-trends-update-in-genai/assets/97929/1089%203%20-%20SPARK%20Patent%20Trends%20Update%20in%20Gen%20AI%20-%20EN.pdf
- USPTO Artificial Intelligence Patent Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/artificial-intelligence-patent-dataset
- USPTO Subject Matter Eligibility page: https://www.uspto.gov/patents/laws/examination-policy/subject-matter-eligibility
- USPTO Patent Assignment Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-assignment-dataset
- USPTO Patent Litigation Docket Reports Data: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-litigation-docket-reports-data
